COMMUNIQUÉS West-GlobeNewswire

Shareholder Update Q3 2018

02/10/2018 - 06:00

Highlights: Venous leg ulcer Phase 2 trial on track: top-line results mid-November Diabetic foot ulcer pilot clinical study: in development with key US researchers Ocular wounds: international patent applications filed [...]

Canada House Wellness Group Reports First Quarter Fiscal Year 2019 Results

02/10/2018 - 03:24

49% Increase in Revenue compared to the same Period in the Prior Year NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness [...]

Eve & Co Files Financial Results for the Three and Nine Month Periods Ended July 31, 2018

02/10/2018 - 02:01

TORONTO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve”) (TSXV: EVE) is pleased to announce that it has filed its interim financial results for the three and nine month periods ended [...]

TESARO Announces Data Presentations at the SITC 2018 Annual Meeting

02/10/2018 - 00:15

WALTHAM, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced that data from a total of five abstracts will be presented at the Society for [...]

BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02/10/2018 - 00:00

CAMBRIDGE, Mass. and BEIJING, China, Oct. 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Assure Holdings Announces Option Issuance

02/10/2018 - 00:00

DENVER, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announces that it has issued an aggregate of [...]

Neon Therapeutics to Present at the Society for Immunotherapy of Cancer 33rd Annual Meeting

01/10/2018 - 23:22

CAMBRIDGE, Mass. , Oct. 01, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced upcoming presentations at [...]

NewLink Genetics Announces Indoximod Biomarker Data and Prodrug NLG802 Pharmacokinetic Data to be Presented at SITC 2018

01/10/2018 - 23:15

AMES, Iowa, Oct. 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that two abstracts were accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 33 rd Annual [...]

Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

01/10/2018 - 23:07

EMERYVILLE, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]

Scholar Rock to Present Preclinical Data Highlighting the Role of TGFβ1 Inhibition in Overcoming Checkpoint Resistance at the SITC Annual Meeting

01/10/2018 - 23:06

CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental [...]

Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures

01/10/2018 - 23:00

LAVAL, Québec, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced its election to issue common shares to the holders of its outstanding [...]

Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results

01/10/2018 - 22:15

SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report third quarter financial [...]

Aduro Biotech Announces Four Abstracts Accepted for Presentation at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting

01/10/2018 - 22:05

Preliminary Phase 1 data for novel STING pathway activator ADU-S100 (MIW815) accepted for presentation BERKELEY, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that four [...]

Aclaris Therapeutics Launches Direct-to-Consumer Campaign for ESKATA® (hydrogen peroxide) Topical Solution 40%, (w/w)

01/10/2018 - 22:01

ESKATA is the First and Only FDA-Approved Topical Treatment for Raised Seborrheic Keratoses WAYNE, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical [...]

GW Pharmaceuticals Announces Proposed Public Offering of ADSs

01/10/2018 - 22:01

LONDON and CARLSBAD, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]

Merit Medical Signs Agreement to Acquire Cianna Medical, Inc.

01/10/2018 - 22:01

SOUTH JORDAN, Utah, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]

Allscripts to present at the 2018 Cantor Fitzgerald Global Healthcare Conference

01/10/2018 - 22:01

CHICAGO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY on [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

01/10/2018 - 22:01

BOSTON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

Align Technology to Announce Third Quarter 2018 Results on October 24, 2018

01/10/2018 - 22:00

SAN JOSE, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report third quarter 2018 financial results on Wednesday, October 24, 2018 after the close [...]